CD33 modulates TREM2: convergence of Alzheimer loci
Gail Chan(Broad Institute), Philip L. De Jager(Brigham and Women's Hospital), David A. Bennett(Rush University Medical Center), Lori B. Chibnik(Harvard University), Julie A. Schneider(Rush University Medical Center), Elizabeth M. Bradshaw(Broad Institute), Reisa A. Sperling(Brigham and Women's Hospital), Phoebe A. Winn, Laura Glick(Yale University), Joseph M. Replogle, Keith A. Johnson(Jacobson Holman (United States)), Katie J. Ryan(Broad Institute), Charles C. White(Brigham and Women's Hospital), Nicole Cuerdon(Broad Institute), Maria Cimpean
Cited by 168
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
|Alzheimer s & Dementia|2012|3.2k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k